Join us for the 3rd ELA Scientific Congress



Written on Thursday 18 December 2014

We are pleased to announce the organization of the 3rd ELA Scientific Congress entitled “Advances in molecular pathogenesis, diagnosis and management of the leukodystrophies” from June 24 to 26, 2015 in Paris, France.

Outstanding speakers with expertise in leukodystrophies, myelin biology, neuroimaging, stem cell research and Gene therapy" class="glossy" title="Procedure involving the insertion of a normal gene into an organism in order to achieve a therapeutic objective. This gene (transgene) can be the normal version of a defective gene causing disease or a gene that produces a protein with any therapeutic action." >gene therapy will participate to the congress to share and discuss recent advances and cutting-edge science in these fields with the ultimate goal to fight and eventually find a cure for the disabling leukodystrophies and myelin diseases.

Confirmed speakers

  • Dr. Stephan Kemp, AMC, Amsterdam, The Netherlands
  • Dr. Yanick Crow, Institut Imagine, Paris, France
  • Pr. Bernard Zalc, ICM Institute, Paris, France
  • Dr. Anne Baron, ICM Institute, Paris, France
  • Dr. Frédéric Sedel, MedDay Pharmaceuticals, Paris, France
  • Pr. Orna Elroy-Stein, Tel-Aviv University, Tel Aviv, Israel
  • Dr. Bruno Stankoff, ICM Institute, Paris, France
  • Dr. Robin Franklin, University of Cambridge, Cambridge, UK
  • Dr. Terri Wood, ICM Institute, Paris, France
  • Dr. Vivi Heine, VU Medical Center, Amsterdam, The Netherlands
  • Dr. Marius Wernig, Stanford University, California, USA
  • Pr. James Provenzale, Duke University, North Carolina, USA
  • Dr. David Rowitch, University of California San Francisco, California, USA
  • Pr. Marjo van der Knapp, VU Medical Center, Amsterdam, The Netherlands
  • Pr. Odile Boespflug-Tanguy, Robert-Debré Hospital, Paris, France

Come back soon on our website for the program, abstract submission and registration.

We look forward to welcoming you in Paris!